FRA7A_ZNF713

Gene
ZNF713
Disease
FRA7A
Inheritance
AD
Classification
Limited
Total Score
2.5
Publications Reviewed
1
Publication Span
10.32 years
Last Updated
08/18/2025
Curator(s)
Laurel Hiatt, Macayla Weiner, Harriet Dashnow

Description

A CGG repeat expansion within the first intron/5' region of ZNF713 underlies the folate-sensitive fragile site FRA7A. A de novo full expansion (>450 repeats) was identified in a male with autism spectrum disorder (ASD), associated with CpG island hypermethylation and reduced ZNF713 expression in patient-derived lymphoblastoid cell lines (LCLs). In a second family, three ASD-affected siblings carried paternal premutation alleles (~42–85 repeats) showing mitotic instability, partial/mosaic methylation, and variable ZNF713 expression including overexpression. Control screening identified only normal alleles (5–22 repeats) in 176 individuals and no additional FRA7A cases in >9,000 cytogenetic analyses. While the repeat expansion demonstrates molecular features consistent with other CGG-repeat disorders, the causal relationship with ASD remains suggestive [@pmid:25196122].

Genetic evidence

Total: 2

Singular EvidenceProbandsPMID:251961221.5Two unrelated families described. Family 7,792 included one proband with a maternally derived full CGG expansion (>450 repeats), FRA7A fragile site, CpG methylation, and reduced ZNF713 expression. Family TCAG0070 included three ASD-affected siblings carrying paternal premutation alleles with evidence of instability, mosaicism, and variable gene expression.
Collective EvidenceSegregationPMID:251961220.5Premutation alleles segregate with ASD in three siblings in one family, but are also present in an unaffected father, indicating reduced penetrance or tissue-specific effects. No full or premutation alleles were observed in controls, however they note that the assay is subject to allelic dropout. No additional FRA7A cases were detected in >9,000 neurodevelopmental cytogenetic analyses. Score is reduced from default because of the small number of individuals, presence of premutation alleles in an unaffected parent, and potential assay limitations.
2 rows

Experimental evidence

Total: 0.5

FunctionRegulatory impactPMID:251961220.5Full expansion allele shows hypermethylation and ~60% reduction of ZNF713 expression in proband LCLs, consistent with repeat-mediated silencing.
1 rows

Note: Maximum score caps apply at evidence type, category, and supercategory levels, so section totals may be lower than the raw sum of row scores.